1. Short title This Act may be cited as the Improved Access to Affordable Medications Act . 2. Amendments to actions for delays of generic drugs and biosimilar biological products Section 610 of division N of the Further Consolidated Appropriations Act, 2020 ( Public Law 116–94 ; 21 U.S.C. 355–2 ) is amended— (1) in subsection (a)— (A) in paragraph (1)(C)— (i) by inserting or contractual terms after additional conditions ; and (ii) by inserting by the license holder after covered product ; (B) in paragraph (2)(A)(iii), by striking including any device and inserting including any packaging, device, or accessory ; (C) by redesignating paragraphs (3) through (10) as paragraphs (4) through (11), respectively; (D) by inserting after paragraph (3) the following: (4) the term designated delivery service means any delivery service provided by a trade or business that the Secretary determines— (A) is available to the general public throughout the United States; (B) records electronically to its database, kept in the regular course of its business, or marks on the cover in which any item referred to in this section is to be delivered, the date on which such item was given to such trade or business for delivery; and (C) provides overnight or 2-day delivery service throughout the United States; ; (E) in paragraph (6), as so redesignated, by inserting including the parent company of such holder after covered product ; and (F) in paragraph (11), as so redesignated— (i) in subparagraph (A), in the matter preceding clause (i), by inserting , at any time, after conduct testing ; and (ii) in subparagraph (B), by inserting , at any time, after fulfill